Par Drugs and Chemicals Limited (NSE:PAR)

Market Cap	1.16B -6.1%
Revenue (ttm)	1.06B +4.8%
Net Income	139.06M -9.9%
EPS	11.31 -9.8%
Shares Out	12.30M
PE Ratio	8.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,338
Average Volume	5,111
Open	92.20
Previous Close	94.08
Day's Range	92.20 - 96.90
52-Week Range	78.05 - 122.43
Beta	-0.04
RSI	60.05
Earnings Date	May 14, 2026

About Par Drugs and Chemicals

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 121
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PAR

Financial Performance

In fiscal year 2025, Par Drugs and Chemicals's revenue was 1.01 billion, an increase of 5.58% compared to the previous year's 956.40 million. Earnings were 133.58 million, a decrease of -7.88%.